<DOC>
	<DOCNO>NCT01640054</DOCNO>
	<brief_summary>The purpose study evaluate long term safety tolerability fostamatinib patient Asia rheumatoid arthritis ( RA ) .</brief_summary>
	<brief_title>A Long Term Study Assess Safety Fostamatinib Patients Asia With Rheumatoid Arthritis</brief_title>
	<detailed_description>( OSKIRA-Asia-1X ) : A Long-term Study Assess Safety Fostamatinib Treatment Rheumatoid Arthritis Asia</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Provision inform consent prior studyspecific procedure . Patients successfully complete study D4300C00008 whose disease adequately control , opinion Investigator . Premature withdrawal study D4300C00008 opinion Investigator patient 's disease adequately control current treatment . Development withdrawal criterion study D4300C00008 Females pregnant breast feed Any clinically significant disease disorder , opinion Investigator might put patient risk due participation study , may influence result study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
</DOC>